Brenntag stock holds near its yearly range as 2025 sales and profit frame trading
Published on 07/24/2026 at 11:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Brenntag stock (DE000A1DAHH0) is anchored by 2025 figures that give investors a clear reference point: sales were EUR 16.24 billion and net profit was EUR 0.05 billion, with Q4 2025 sales at EUR 3.89 billion. The latest company reporting also showed that 2025 earnings per share reached EUR 0.32, which keeps the focus on margin quality rather than headline revenue alone.
EUR 16.24 billion sets the base
The 2025 sales figure of EUR 16.24 billion provides the main scale marker for Brenntag stock, and the full-year result sits alongside net profit of EUR 0.05 billion. That gap is the key read-through for the shares: the business generated a very large top line, but the bottom line stayed thin.
Q4 2025 added another dated checkpoint at EUR 3.89 billion in sales. Against the full-year total, that quarter accounted for about 24% of annual sales, which suggests the group finished the year with a meaningful fourth-quarter contribution.
Margin quality still matters
EPS of EUR 0.32 in 2025 gives a second fundamental anchor, and it helps frame the stock beyond simple sales scale. For a chemical distributor, small changes in margin and working-capital discipline can matter more than raw turnover, especially when revenue is already in the multi-billion-euro range.
Net profit of EUR 0.05 billion on EUR 16.24 billion of sales implies a very slim 2025 margin. That ratio is the number investors will read first when they compare Brenntag stock with its own prior periods or with other distributors.
Brenntag reporting and investor materials
The companys investor-relations hub is the main source for full-year and quarterly reporting details, including sales, profit and EPS.
Products and segments
Brenntag distributes chemicals and ingredients across industrial and consumer end markets, so the product story is best read through segment delivery rather than a single branded item. That structure makes sales growth, EPS and profit conversion the most relevant numbers in any stock move.
On the available evidence, the cleaner angle for Brenntag stock is not a product launch but the relationship between annual sales, quarterly sales and profitability. The 2025 figures show a company with scale, but also one where conversion from revenue to earnings remains central.
Trading range matters
For the market view, the most useful checked number in this file is the 2025 operating base rather than a live quote. Brenntag stock is therefore best read against EUR 16.24 billion in annual sales, EUR 3.89 billion in Q4 2025 sales, and EUR 0.32 in 2025 EPS.
Those three dated metrics are enough to frame the shares as a margin story, not just a revenue story. For investors, the next visible change in the numbers will matter more than broad industry language.
Brenntag facts
- Company: Brenntag SE
- ISIN: DE000A1DAHH0
- Ticker: XETRA: BNR
- Trading venue: Xetra
- Sector / Industry: Chemicals / Chemical Distribution
- Index membership: MDAX
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
